Occupational health study links air pollution and cancer

November 26, 2018, University of Stirling
Credit: CC0 Public Domain

University of Stirling experts have discovered new evidence of the link between air pollution and cancer as part of a new occupational health study.

The team, from the Faculty of Health Sciences and Sport, analysed the case of a woman who developed after spending 20 years working as a border guard at the busiest commercial border crossing in North America.

The woman was one of, at least, five other border guards who developed breast cancer within 30 months of each other and, at another nearby crossing, a cluster of seven other cases was noted.

Dr. Michael Gilbertson, who worked with colleague Dr. Jim Brophy, said their findings "infer a causal relationship" between breast cancer and very high exposures to traffic-related air pollution containing mammary carcinogens. A link between nightshift work and cancer was also identified.

Dr. Gilbertson said: "This new research indicates the role of traffic-related air pollution in contributing to the increasing incidence of breast cancer in the general population.

"With this new knowledge, industry and government can plan for new designs for industrial and commercial facilities to cut down on the occupational exposures to traffic-related air pollution and for scheduling shift work to minimise disruption of sleep patterns."

Drs Gilbertson and Brophy focused on the worker compensation case of the woman, who was employed by the Canada Border Services Agency for two decades at the Ambassador Bridge, which crosses the Detroit River between Windsor, Ontario, and Detroit, Michigan.

The bridge – the busiest commercial border crossing in North America – carries 12,000 trucks and 15,000 cars each day. The air pollution is severe and border guards in the traffic booths inhale many carcinogens, including those that result in breast cancer.

The woman – one of at least five colleagues who developed breast cancer within 30 months of each other – was diagnosed with her first bout of breast cancer at the age of 44 and second at 51. Notably, another cluster of seven cancer cases occurred at a second crossing point, the Detroit-Windsor Tunnel, which lies four miles from the bridge.

The cluster of cases in staff at the bridge was 16 times higher than the rate in the rest of the country – there is less than a one in 10,000 probability that this could have occurred by chance. In addition, the clusters were characterised by breast cancer that were early onset and premenopausal with recurrences.

The scientists analysed the circumstances of the case – heard by the Workplace Safety and Insurance Appeals Tribunal (WSIAT) – by applying the Bradford Hill criteria – a group of nine principles that are useful in establishing epidemiologic evidence of a causal relationship between a presumed cause and an observed effect. The criteria considers strength, consistency, specificity, temporality, biological gradient, plausibility, coherence, experiment and analogy.

The case focused on whether the woman had a genetically inherited predisposition to develop breast cancer because of dysfunctional BRCA1/2 tumour suppressor genes. It was found that her BRCA1/2 tumour suppressors were not working – but that was not connected to her inherited genes. This condition is known as "BRCAness" and is sporadic, rather than an inherited breast cancer.

The Stirling team investigated whether the dysfunction was potentially caused by occupational exposures to pollution. A review of previous research confirmed that BRCA1 can be "silenced" by exposures to dioxins and polycyclic aromatic hydrocarbons – both found in exhaust fumes.

In addition, other research has shown that BRCA2 is rapidly degraded in the presence of aldehydes – also components of exhaust fumes.

"There is much more research to be undertaken," Dr. Gilbertson said. "But we now have plausible mechanisms for inferring how the BRCA1/2 tumour suppressors in this highly-exposed border guard became dysfunctional and likely contributed to the ongoing epidemic of sporadic, early onset, premenopausal breast cancer among her colleagues.

"These outbreaks of breast cancer represent a new occupational disease that we are provisionally calling 'occupational BRCAness'."

The front-line workers also identified nightshift work as a potential contributing factor to their high incidence of .

Drs Gilbertson and Brophy considered whether nightshift work might exacerbate the exposures to mammary carcinogens in traffic-related .

They pointed to a previous study involving rats that found those exposed to continuous daylight developed tumours 36 per cent faster – and had 60 per cent more tumours – than those subjected to a normal photoperiod.

Significantly, the WSIAT rejected the woman's case.

Reflecting on the findings, Dr. Gilbertson continued: "Reweighing the scientific evidence using a consensus medico-legal framework – the Hill Bradford criteria – enabled us to show the amount of evidence that the WSIAT had ignored in dismissing this worker compensation case."

He added: "This kind of forensic research depends on asking new questions based on conclusions from the existing evidence and a willingness to follow leads into unfamiliar areas of science.

"The gratifying part was to find that other scientists in other disciplines had already supplied credible answers that could then be assembled into the Hill's framework of indicia for this specific case which can explain the clusters."

Explore further: Does your job increase your breast cancer risk?

More information: Michael Gilbertson et al. Causality Advocacy: Workers' Compensation Cases as Resources for Identifying and Preventing Diseases of Modernity, NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy (2018). DOI: 10.1177/1048291118810900

Related Stories

Does your job increase your breast cancer risk?

November 19, 2012
Is there a link between the risk of breast cancer and the working environment? A study published in BioMed Central's open access journal Environmental Health provides further evidence on this previously neglected research ...

Familial breast cancer not only inherited genetically, finds new study

February 28, 2018
Mutations in known breast cancer genes such as BRCA1 and BRCA2 are identified in only approximately 20 per cent of women who are offered genetic testing for familial breast cancer.

Team identifies genes that increase risk for triple-negative breast cancer

August 7, 2018
A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal ...

Increased adiposity tied to lower premenopausal breast CA risk

June 25, 2018
(HealthDay)—Across body mass index (BMI) distribution, increased BMI is associated with reduced risk of premenopausal breast cancer, according to a study published online June 21 in JAMA Oncology.

Genetic predisposition to breast cancer due to non-brca mutations in ashkenazi Jewish women

July 20, 2017
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing mutation ...

Exposure to environmental chemicals is an important risk factor for breast cancer

October 10, 2017
Exposure to environmental chemicals, especially early in life, is an important contributing factor in the development of breast cancer, according to the most comprehensive review of human studies to date. The findings could ...

Recommended for you

Potential seen for tailoring treatment for acute myeloid leukemia

December 8, 2018
Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML).

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Inflammatory bowel disease linked to prostate cancer

December 7, 2018
Men with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, reports a 20-year study from Northwestern Medicine.

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

Scientists develop new technology for profiling unique genetic makeup of myeloma tumor cells

December 6, 2018
Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells—outlining how cancer cells hijack specific pathways for uncontrolled proliferation—will lead to more efficient ways to fight it. Joint ...

Putting the brakes on tumor stealth

December 6, 2018
New research undertaken at Monash University has shed new light on how some cancers are able to escape our immune system.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.